Verrica Pharmaceuticals (VRCA) Return on Equity [ROE] (2018 - 2026)
Verrica Pharmaceuticals (VRCA) posted Return on Equity [ROE] of -308.74% for Q2 2026, down 217.19 percentage points from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Verrica Pharmaceuticals' Return on Equity [ROE] came in at -255.30%, up 1237.46 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -168.17 percentage points (FY2020 to FY2025).
- In prior years, Verrica Pharmaceuticals' Return on Equity [ROE] was -1492.76% in FY2024 (-1268.73 pp), -224.03% in FY2023 (-160.73 pp), -63.31% in FY2022 (+43.66 pp) and -106.97% in FY2021 (-19.84 pp).
- Quarterly Return on Equity [ROE] has run from a low of -758.88% in Q1 2024 to a high of -36.57% in Q2 2023 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2023, with a gain of 159.86 percentage points; the weakest was Q1 2024, with a drop of 718.52 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Verrica Pharmaceuticals | 82.46 Mn | -588,823.92 | - | -308.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -308.74% |
| Mar 31, 2026 | -91.55% |
| Dec 31, 2025 | -493.26% |
| Mar 31, 2024 | -758.88% |
| Dec 31, 2023 | -215.83% |
| Sep 30, 2023 | -98.78% |
| Jun 30, 2023 | -36.57% |
| Mar 31, 2023 | -40.36% |
| Dec 31, 2022 | -54.36% |
| Sep 30, 2022 | -87.28% |
| Jun 30, 2022 | -196.43% |
| Mar 31, 2022 | -146.89% |
| Dec 31, 2021 | -95.51% |
| Sep 30, 2021 | -82.83% |
| Jun 30, 2021 | -63.48% |
| Mar 31, 2021 | -71.33% |
| Dec 31, 2020 | -118.32% |
| Sep 30, 2020 | -85.24% |
| Jun 30, 2020 | -62.73% |
| Mar 31, 2020 | -50.23% |
API Access
Verrica Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();